Bayer HealthCare enters strategic partnership with pharmaceuticals manufacturer

As reported in Russian business daily Vedomosti on 2 November 2012, Bayer HealthCare has decided to consolidated its position in Russia through strategic partnership with Sverdlovsk-based pharmaceuticals manufacturer Medsintez.

They will jointly manufacture and commercialise diagnostic imaging products and also pharmaceuticals to combat infections and neural disorders. The two firms have also announced plans to cooperate in R&D and manufacture of new substances and medicines.

Localisation should enable Bayer to leverage preferential terms in state tenders.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: